Sanctuary Wealth Management’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-9
Closed -$1.07K 282
2024
Q2
$1.07K Hold
9
﹤0.01% 231
2024
Q1
$959 Hold
9
﹤0.01% 240
2023
Q4
$895 Hold
9
﹤0.01% 250
2023
Q3
$930 Hold
9
﹤0.01% 240
2023
Q2
$1.09K Buy
+9
New +$1.2K ﹤0.01% 239
2022
Q4
$1.62K Buy
+9
New +$1.47K ﹤0.01% 197

Other funds holding MRNA

Sanctuary Wealth Management's MRNA Position: Q3 2024 in Review

Sanctuary Wealth Management sold out of Moderna (MRNA) in Q3 2024, closing a stake of 9 shares — an estimated $1.07K sold.

Sanctuary Wealth Management first reported a position in MRNA in Q4 2022 and held it in 6 quarters. The position peaked at $1.62K in Q4 2022. 788 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • Sanctuary Wealth Management reported no remaining Moderna position as of Q3 2024 after selling out during the quarter.
  • Sanctuary Wealth Management sold 9 Moderna shares in Q3 2024, an estimated $1.07K.
  • Sanctuary Wealth Management first reported a position in Moderna in Q4 2022 and held it in 6 quarters.
  • Sanctuary Wealth Management's Moderna position peaked at $1.62K in Q4 2022.
  • 788 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on Sanctuary Wealth Management's 13F filing for Q3 2024, filed 4 Nov 2024.